Indaptus Therapeutics, Inc.
8-K
May 15, 2026
Key Highlights
- Active reassessment of the 'Decoy' platform to optimize capital allocation
- Aggressive cost-cutting measures implemented to preserve remaining runway
- Simplified capital structure following the conversion of Series A preferred stoc...
Read Analysis
🤖 AI Generated